Norges Bank has increased its stake in Cabaletta Bio, Inc. to 4.02%, reflecting ongoing investment in the biological products sector.
| Name | Cabaletta Bio, Inc. |
|---|---|
| CIK | 0001759138 |
| Tickers | CABA |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Non-accelerated filer<br>Smaller reporting company |
| SIC | 2836 Biological Products, (No Diagnostic Substances) |
| EIN | 000000000 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | DE DE |
| Phone | (267) 759-3100 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
Norges Bank has increased its stake in Cabaletta Bio, Inc. to 4.02%, reflecting ongoing investment in the biological products sector.
Cabaletta Bio, Inc. reports promising Phase 1/2 clinical data for rese-cel, indicating significant advances in autoimmune disease treatment.
Cabaletta Bio, Inc. has released its Q3 financial results, showcasing key metrics and developments in biological products. Read more about the impact on the industry.
Cabaletta Bio, Inc. announces its Q3 2026 financial results, showcasing growth in the biological products sector.
454 filing rows loaded from submissions recent.
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-005291 | 005-91178 | 261559136 | 34 | 9761 | |||
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-461980 | 005-91178 | 261555301 | 34 | 8956 | |||
| 2026-11-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001374170-26-000074 | 005-91178 | 261543240 | 34 | 7570 | |||
| 2026-11-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001759138-26-000050 | 001-39103 | 261533627 | 34 | 26267253 | 1 | 1 |
| 2026-11-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000706 | 005-91178 | 261530260 | 34 | 9485 | |||
| 2026-11-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000701 | 005-91178 | 261530167 | 34 | 7702 | |||
| 2026-11-05 | 10-Q | 10-Q | 0001759138-26-000047 | 001-39103 | 261524824 | 34 | 9035751 | 1 | 1 | |
| 2026-11-05 | 8-K | 8-K | 2.02,9.01 | 0001759138-26-000046 | 001-39103 | 261524811 | 34 | 336374 | 1 | 1 |
| 2026-10-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-001567 | 005-91178 | 261505531 | 34 | 7543 | |||
| 2026-10-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-003765 | 005-91178 | 261491632 | 34 | 10901 | |||
| 2026-09-14 | 8-K | 8-K | 8.01 | 0001759138-26-000041 | 001-39103 | 261375854 | 34 | 154308 | 1 | 1 |
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003687 | 005-91178 | 261279654 | 34 | 10462 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001897612-26-000608 | 005-91178 | 261277504 | 34 | 7704 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001193125-26-350333 | 005-91178 | 261275991 | 34 | 9344 | |||
| 2026-08-13 | 10-Q | 10-Q | 0001759138-26-000039 | 001-39103 | 261270077 | 34 | 9049540 | 1 | 1 | |
| 2026-08-13 | 8-K | 8-K | 2.02,9.01 | 0001759138-26-000038 | 001-39103 | 261270073 | 34 | 322433 | 1 | 1 |
| 2026-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000919574-26-004972 | 005-91178 | 261266236 | 34 | 13087 | |||
| 2026-08-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001374170-26-000058 | 005-91178 | 261265231 | 34 | 7534 | |||
| 2026-07-31 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-001326 | 005-91178 | 261225843 | 34 | 7441 | |||
| 2026-07-27 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002012383-26-002220 | 005-91178 | 261206095 | 34 | 10843 | |||
| 2026-07-23 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001104659-26-086361 | 005-91178 | 261197948 | 34 | 15879 | |||
| 2026-06-11 | 8-K | 8-K | 5.03,5.07,9.01 | 0001759138-26-000033 | 001-39103 | 261081418 | 34 | 233802 | 1 | 1 |
| 2026-06-10 | 4 | 4 | 0001193125-26-266239 | 5446 | ||||||
| 2026-06-10 | 4 | 4 | 0001193125-26-266232 | 5339 | ||||||
| 2026-06-10 | 4 | 4 | 0001193125-26-266229 | 5363 | ||||||
| 2026-06-10 | 4 | 4 | 0001193125-26-266224 | 5359 | ||||||
| 2026-06-10 | 4 | 4 | 0001193125-26-266220 | 5351 | ||||||
| 2026-06-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001137774-26-000127 | 005-91178 | 261068444 | 34 | 7274 | |||
| 2026-06-04 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000053417-26-000042 | 005-91178 | 261065223 | 34 | 6611 | |||
| 2026-06-03 | 8-K | 8-K | 7.01,8.01,9.01 | 0001759138-26-000030 | 001-39103 | 261058900 | 34 | 28231115 | 1 | 1 |
| 2026-06-01 | DEFA14A | DEFA14A | 0001193125-26-249726 | 001-39103 | 261047168 | 34 | 27867 | |||
| 2026-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002219 | 005-91178 | 26985223 | 34 | 10417 | |||
| 2026-05-14 | 10-Q | 10-Q | 0001759138-26-000026 | 001-39103 | 26975804 | 34 | 7665742 | 1 | 1 | |
| 2026-05-14 | 8-K | 8-K | 2.02,9.01 | 0001759138-26-000025 | 001-39103 | 26975801 | 34 | 300392 | 1 | 1 |
| 2026-05-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001759138-26-000024 | 001-39103 | 26975789 | 34 | 28018084 | 1 | 1 |
| 2026-05-04 | 8-K | 8-K | 1.01,2.02,8.01,9.01 | 0001193125-26-202446 | 001-39103 | 26934559 | 34 | 8051565 | 1 | 1 |
| 2026-05-04 | 424B5 | 424B5 | 0001193125-26-202441 | 333-278126 | 26934556 | 33 | 660983 | |||
| 2026-05-04 | 8-K | 8-K | 8.01,9.01 | 0001193125-26-202389 | 001-39103 | 26934488 | 34 | 152626 | 1 | 1 |
| 2026-04-28 | ARS | ARS | 0001193125-26-183571 | 001-39103 | 26903161 | 34 | 1436538 | |||
| 2026-04-28 | DEFA14A | DEFA14A | 0001193125-26-183564 | 001-39103 | 26903155 | 34 | 470582 | |||
| 2026-04-28 | DEF 14A | DEF 14A | 0001193125-26-183557 | 001-39103 | 26903147 | 34 | 3199425 | 1 | 1 | |
| 2026-04-20 | 8-K | 8-K | 8.01,9.01 | 0001759138-26-000016 | 001-39103 | 26873334 | 34 | 27884519 | 1 | 1 |
| 2026-04-17 | PRE 14A | PRE 14A | 0001193125-26-160326 | 001-39103 | 26869415 | 34 | 3180264 | 1 | 1 | |
| 2026-03-23 | S-8 | S-8 | 0001759138-26-000013 | 333-294514 | 26779914 | 33 | 442228 | 1 | 1 | |
| 2026-03-23 | 10-K | 10-K | 0001759138-26-000011 | 001-39103 | 26779910 | 34 | 14952232 | 1 | 1 | |
| 2026-03-23 | 8-K | 8-K | 2.02,7.01,9.01 | 0001759138-26-000010 | 001-39103 | 26779905 | 34 | 26440930 | 1 | 1 |
| 2026-03-02 | 4 | 4 | 0001193125-26-086145 | 5397 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-086143 | 5460 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-086135 | 5421 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-086129 | 5408 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-086123 | 5413 | ||||||
| 2026-03-02 | 4 | 4 | 0001193125-26-086118 | 5399 | ||||||
| 2026-02-18 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-26-017121 | 005-91178 | 26649855 | 34 | 15201 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001156 | 005-91178 | 26642377 | 34 | 10742 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001031 | 005-91178 | 26640007 | 34 | 10322 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-26-000278 | 005-91178 | 26637802 | 34 | 9361 | |||
| 2026-01-21 | 4 | 4 | 0001193125-26-018327 | 4426 | ||||||
| 2026-01-21 | 4 | 4 | 0001193125-26-018325 | 4443 | ||||||
| 2026-01-21 | 4 | 4 | 0001193125-26-018324 | 4602 | ||||||
| 2026-01-21 | 4 | 4 | 0001193125-26-018323 | 4982 | ||||||
| 2026-01-21 | 4 | 4 | 0001193125-26-018319 | 4371 | ||||||
| 2026-01-21 | 4 | 4 | 0001193125-26-018318 | 6030 | ||||||
| 2026-01-21 | 4 | 4 | 0001193125-26-018317 | 5596 | ||||||
| 2026-01-21 | 4 | 4 | 0001193125-26-018316 | 4960 | ||||||
| 2026-01-12 | 8-K | 8-K | 7.01,8.01 | 0001193125-26-009819 | 001-39103 | 26524739 | 34 | 25923735 | 1 | 1 |
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-005189 | 005-91178 | 251489021 | 34 | 10739 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-112515 | 005-91178 | 251486127 | 34 | 18485 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-004955 | 005-91178 | 251483879 | 34 | 11551 | |||
| 2025-11-10 | 10-Q | 10-Q | 0001193125-25-273280 | 001-39103 | 251464370 | 34 | 9273000 | 1 | 1 | |
| 2025-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-25-273272 | 001-39103 | 251464361 | 34 | 324795 | 1 | 1 |
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001137774-25-000181 | 005-91178 | 251461857 | 34 | 7305 | |||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000509 | 005-91178 | 251461663 | 34 | 9368 | |||
| 2025-11-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001897612-25-000506 | 005-91178 | 251461653 | 34 | 7580 | |||
| 2025-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000053417-25-000098 | 005-91178 | 251453163 | 34 | 6519 | |||
| 2025-10-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-25-254610 | 001-39103 | 251426774 | 34 | 27607042 | 1 | 1 |
| 2025-10-27 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-250676 | 001-39103 | 251417430 | 34 | 26146561 | 1 | 1 |
| 2025-10-15 | 4 | 4 | 0001193125-25-240356 | 5715 | ||||||
| 2025-10-15 | 3 | 3 | 0001193125-25-240316 | 16566 | ||||||
| 2025-10-09 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-235533 | 001-39103 | 251384065 | 34 | 26058086 | 1 | 1 |
| 2025-09-03 | 8-K | 8-K | 7.01,9.01 | 0001759138-25-000007 | 001-39103 | 251287660 | 34 | 21806851 | 1 | 1 |
| 2025-08-15 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-002642 | 333-289339 | 251226184 | 33 | 1769 | ||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003544 | 005-91178 | 251221246 | 34 | 11115 | |||
| 2025-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-108821 | 005-91178 | 251218358 | 34 | 9244 | |||
| 2025-08-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003433 | 005-91178 | 251217841 | 34 | 10775 | |||
| 2025-08-13 | CORRESP | filename1.htm | 0001193125-25-179840 | 6681 | ||||||
| 2025-08-13 | UPLOAD | filename1.pdf | 0000000000-25-008485 | 333-289339 | 40137 | |||||
| 2025-08-12 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-003505 | 005-91178 | 251204572 | 34 | 13122 | |||
| 2025-08-11 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001470831-25-000124 | 005-91178 | 251202399 | 34 | 6989 | |||
| 2025-08-07 | S-3 | S-3 | 0001193125-25-175003 | 333-289339 | 251191779 | 33 | 1664673 | 1 | 1 | |
| 2025-08-07 | 10-Q | 10-Q | 0000950170-25-104573 | 001-39103 | 251191655 | 34 | 9661000 | 1 | 1 | |
| 2025-08-07 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-104570 | 001-39103 | 251191643 | 34 | 323827 | 1 | 1 |
| 2025-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000053417-25-000082 | 005-91178 | 251189787 | 34 | 6519 | |||
| 2025-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001137774-25-000122 | 005-91178 | 251188932 | 34 | 7301 | |||
| 2025-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000810 | 005-91178 | 251159092 | 34 | 6272 | |||
| 2025-07-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002052113-25-002491 | 005-91178 | 251128407 | 34 | 10718 | |||
| 2025-06-20 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001104659-25-061235 | 005-91178 | 251062390 | 34 | 27915 | |||
| 2025-06-12 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-25-139517 | 001-39103 | 251041600 | 34 | 683174 | 1 | 1 |
| 2025-06-12 | 424B5 | 424B5 | 0001193125-25-139512 | 333-278126 | 251041591 | 33 | 713733 | |||
| 2025-06-11 | 424B5 | 424B5 | 0001193125-25-138755 | 333-278126 | 251038744 | 33 | 716715 | |||
| 2025-06-11 | 8-K | 8-K | 1.02,7.01,8.01,9.01 | 0001193125-25-138737 | 001-39103 | 251038723 | 34 | 5784931 | 1 | 1 |
| 2025-06-10 | 8-K | 8-K | 5.03,5.07,9.01 | 0001193125-25-137954 | 001-39103 | 251035283 | 34 | 175628 | 1 | 1 |
| 2025-06-09 | 4 | 4 | 0000950170-25-084022 | 5202 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-084019 | 5214 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-084017 | 5222 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-084015 | 5309 | ||||||
| 2025-06-09 | 4 | 4 | 0000950170-25-084014 | 5226 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074832 | 17189 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074826 | 29701 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074825 | 21377 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074824 | 21332 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074823 | 13150 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074818 | 33809 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074817 | 21308 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074816 | 29664 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074811 | 25525 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074810 | 21304 | ||||||
| 2025-05-19 | 4 | 4 | 0000950170-25-074808 | 33790 | ||||||
| 2025-05-19 | 8-K | 8-K | 5.02 | 0000950170-25-074589 | 001-39103 | 25965158 | 34 | 152372 | 1 | 1 |
| 2025-05-15 | 10-Q | 10-Q | 0000950170-25-071971 | 001-39103 | 25948662 | 34 | 7376449 | 1 | 1 | |
| 2025-05-15 | 8-K | 8-K | 2.02,7.01,9.01 | 0000950170-25-071966 | 001-39103 | 25948640 | 34 | 226504 | 1 | 1 |
| 2025-05-13 | ARS | ARS | 0001193125-25-118332 | 001-39103 | 25937232 | 34 | 1335195 | |||
| 2025-05-13 | DEF 14A | DEF 14A | 0001193125-25-118330 | 001-39103 | 25937224 | 34 | 3370716 | 1 | 1 | |
| 2025-04-30 | PRE 14A | PRE 14A | 0001193125-25-105790 | 001-39103 | 25891074 | 34 | 3383837 | 1 | 1 | |
| 2025-03-31 | EFFECT | xslEFFECTX01/primary_doc.xml | ,, | 9999999995-25-000868 | 333-278126 | 25796301 | 33 | 1781 | ||
| 2025-03-31 | S-8 | S-8 | 0000950170-25-047233 | 333-286246 | 25789077 | 33 | 174220 | |||
| 2025-03-31 | POS AM | POS AM | 0001193125-25-067883 | 333-278126 | 25789046 | 33 | 694157 | |||
| 2025-03-31 | 10-K | 10-K | 0000950170-25-047201 | 001-39103 | 25788880 | 34 | 14109495 | 1 | 1 | |
| 2025-03-31 | POSASR | POSASR | 0001193125-25-067749 | 333-278126 | 25788828 | 33 | 650153 | |||
| 2025-03-31 | 8-K | 8-K | 2.02,9.01 | 0000950170-25-047196 | 001-39103 | 25788810 | 34 | 308004 | 1 | 1 |
| 2025-03-04 | 4 | 4 | 0000950170-25-032326 | 5425 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032314 | 5406 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032303 | 5385 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032299 | 5401 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032295 | 5412 | ||||||
| 2025-03-04 | 4 | 4 | 0000950170-25-032271 | 5417 | ||||||
| 2025-02-18 | 8-K/A | 8-K/A | 7.01,8.01,9.01 | 0001193125-25-028420 | 001-39103 | 25633993 | 34 | 191313 | 1 | 1 |
| 2025-02-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-25-028143 | 001-39103 | 25632715 | 34 | 4076065 | 1 | 1 |
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001192 | 005-91178 | 25592178 | 34 | 11777 | |||
| 2025-01-13 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-25-005016 | 001-39103 | 25524924 | 34 | 6552812 | 1 | 1 |
| 2024-12-06 | SC 13G/A | CABALETTA BIO, INC. | 0001193125-24-272447 | 005-91178 | 241532300 | 34 | 47868 | |||
| 2024-12-05 | SC 13G/A | caba2.htm | 0001137774-24-000286 | 005-91178 | 241529726 | 34 | 9398 | |||
| 2024-12-05 | SC 13G/A | CABA 11302024 13G/A | 0000053417-24-000112 | 005-91178 | 241528954 | 34 | 8794 | |||
| 2024-11-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-260425 | 001-39103 | 241469745 | 34 | 18133248 | 1 | 1 |
| 2024-11-14 | SC 13G/A | SC 13G/A | 0001104659-24-119311 | 005-91178 | 241464751 | 34 | 165358 | |||
| 2024-11-14 | SC 13G/A | CABALETTA BIO, INC. | 0001193125-24-258531 | 005-91178 | 241461635 | 34 | 47119 | |||
| 2024-11-14 | SC 13G | caba13gsep24.txt | 0001897612-24-001980 | 005-91178 | 34 | 6508 | ||||
| 2024-11-14 | 10-Q | 10-Q | 0000950170-24-126733 | 001-39103 | 241457155 | 34 | 8410896 | 1 | 1 | |
| 2024-11-14 | 8-K | 8-K | 2.02,9.01 | 0000950170-24-126731 | 001-39103 | 241457141 | 34 | 290277 | 1 | 1 |
| 2024-11-12 | SC 13G/A | UnitedStates_13G__CabalettaB.txt | 0000932471-24-000852 | 005-91178 | 241446482 | 34 | 6567 | |||
| 2024-11-12 | SC 13G/A | CABALETTA BIO, INC. | 0000902664-24-006409 | 005-91178 | 241444233 | 34 | 72354 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__CabalettaB.txt | 0000932471-24-000312 | 005-91178 | 241421802 | 34 | 5632 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__CabalettaB.txt | 0000932471-24-000389 | 005-91178 | 241421595 | 34 | 5632 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__CabalettaB.txt | 0000932471-24-000388 | 005-91178 | 241421593 | 34 | 5632 | |||
| 2024-10-17 | SC 13G/A | Cabaletta_Bio_Inc.htm | 0000093751-24-000814 | 005-91178 | 241376658 | 34 | 55858 | |||
| 2024-10-07 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-233294 | 001-39103 | 241356037 | 34 | 3500802 | 1 | 1 |
| 2024-09-30 | 8-K | 8-K | 1.01 | 0000950170-24-110389 | 001-39103 | 241339864 | 34 | 163285 | 1 | 1 |
| 2024-08-22 | SC 13G | SC 13G | 0001193125-24-205483 | 005-91178 | 241233070 | 34 | 51550 | |||
| 2024-08-08 | 10-Q | 10-Q | 0000950170-24-093325 | 001-39103 | 241186052 | 34 | 7811142 | 1 | 1 | |
| 2024-08-08 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-24-196467 | 001-39103 | 241185990 | 34 | 3680685 | 1 | 1 |
| 2024-06-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-161089 | 001-39103 | 241043017 | 34 | 9458205 | 1 | 1 |
| 2024-06-10 | SC 13G | CABALETTA.HTM | 0001137774-24-000084 | 005-91178 | 241033571 | 34 | 9442 | |||
| 2024-06-06 | SC 13G | 13G MONTHLY FILING - CABA | 0000053417-24-000060 | 005-91178 | 241024450 | 34 | 8785 | |||
| 2024-06-04 | 4 | 4 | 0000950170-24-068996 | 5233 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068993 | 5213 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068992 | 5237 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068984 | 5225 | ||||||
| 2024-06-04 | 4 | 4 | 0000950170-24-068982 | 5320 | ||||||
| 2024-06-04 | 8-K | 8-K | 5.07 | 0001193125-24-154309 | 001-39103 | 241018684 | 34 | 155541 | 1 | 1 |
| 2024-05-15 | 10-Q | 10-Q | 0000950170-24-060045 | 001-39103 | 24947211 | 34 | 7020152 | 1 | 1 | |
| 2024-05-15 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-24-138874 | 001-39103 | 24947104 | 34 | 10506558 | 1 | 1 |
| 2024-04-23 | ARS | ARS | 0001193125-24-105900 | 001-39103 | 24862680 | 34 | 3608511 | |||
| 2024-04-23 | DEFA14A | DEFA14A | 0001193125-24-105890 | 001-39103 | 24862673 | 34 | 162363 | |||
| 2024-04-23 | DEF 14A | DEF 14A | 0001193125-24-105870 | 001-39103 | 24862666 | 34 | 624801 | |||
| 2024-03-21 | S-3ASR | S-3ASR | 0001193125-24-073325 | 333-278126 | 24769533 | 33 | 1435581 | |||
| 2024-03-21 | S-8 | S-8 | 0001193125-24-073318 | 333-278124 | 24769496 | 33 | 55259 | |||
| 2024-03-21 | 10-K | 10-K | 0000950170-24-034422 | 001-39103 | 24769419 | 34 | 10368131 | 1 | 1 | |
| 2024-03-21 | 8-K | 8-K | 2.02,9.01 | 0001193125-24-073294 | 001-39103 | 24769408 | 34 | 224506 | 1 | 1 |
| 2024-03-20 | 8-K | 8-K | 7.01,9.01 | 0001193125-24-072048 | 001-39103 | 24766272 | 34 | 178019 | 1 | 1 |
| 2024-03-04 | 4 | 4 | 0000950170-24-025039 | 5389 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025027 | 5416 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025012 | 5421 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025004 | 5410 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-025002 | 5405 | ||||||
| 2024-03-04 | 4 | 4 | 0000950170-24-024978 | 5470 | ||||||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-024234 | 005-91178 | 24641713 | 34 | 152162 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001104659-24-023726 | 005-91178 | 24638755 | 34 | 98645 | |||
| 2024-02-14 | SC 13G/A | CABALETTA BIO, INC. | 0001193125-24-036204 | 005-91178 | 24638212 | 34 | 50361 | |||
| 2024-02-14 | SC 13G/A | formsc13ga.htm | 0001493152-24-006619 | 005-91178 | 24637779 | 34 | 91553 | |||
| 2024-02-14 | SC 13G/A | AMENDMENT NO. 2 | 0000929638-24-000640 | 005-91178 | 24636478 | 34 | 123045 | |||
| 2024-02-14 | SC 13G/A | CABALETTA BIO, INC. | 0000902664-24-001609 | 005-91178 | 24633030 | 34 | 67267 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-034084 | 005-91178 | 24630862 | 34 | 49537 | |||
| 2024-02-13 | SC 13G/A | SC 13G/A | 0001193125-24-033809 | 005-91178 | 24626613 | 34 | 47182 | |||
| 2024-02-12 | SC 13G/A | e619242_sc13ga-cb.htm | 0001193805-24-000180 | 005-91178 | 24621415 | 34 | 130555 | |||
| 2024-02-07 | SC 13G/A | CABALETTA BIO, INC. | 0000902664-24-001128 | 005-91178 | 24602104 | 34 | 98734 | |||
| 2024-02-01 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-24-021894 | 001-39103 | 24587472 | 34 | 191758 | 1 | 1 |
| 2024-01-24 | SC 13G | Cabaletta_Bio_Inc.txt | 0000093751-24-000134 | 005-91178 | 24554728 | 34 | 8476 | |||
| 2024-01-19 | 4 | 4 | 0000950170-24-005888 | 10849 | ||||||
| 2024-01-08 | SC 13G | us12674w1099_010824.txt | 0001086364-24-000182 | 005-91178 | 24520611 | 34 | 13495 | |||
| 2024-01-08 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-24-003872 | 001-39103 | 24518314 | 34 | 9330373 | 1 | 1 |
| 2023-12-19 | 4 | 4 | 0000950170-23-071689 | 10850 | ||||||
| 2023-11-21 | 4 | 4 | 0000950170-23-065521 | 10768 | ||||||
| 2023-11-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-005215 | 001-39103 | 231422963 | 33 | 6900 | |||
| 2023-11-09 | 10-Q | 10-Q | 0000950170-23-061528 | 001-39103 | 231390057 | 34 | 8878895 | 1 | 1 | |
| 2023-11-09 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-23-274053 | 001-39103 | 231390032 | 34 | 4887705 | 1 | 1 |
| 2023-11-06 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-270840 | 001-39103 | 231378081 | 34 | 190113 | 1 | 1 |
| 2023-10-19 | 4 | 4 | 0000950170-23-054234 | 10766 | ||||||
| 2023-10-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004577 | 001-39103 | 231334772 | 33 | 6175 | |||
| 2023-10-02 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-248186 | 001-39103 | 231297742 | 34 | 14882204 | 1 | 1 |
| 2023-09-20 | 4 | 4 | 0000950170-23-049005 | 10764 | ||||||
| 2023-09-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-004172 | 001-39103 | 231264116 | 33 | 6900 | |||
| 2023-09-05 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-228144 | 001-39103 | 231234244 | 34 | 4112555 | 1 | 1 |
| 2023-08-22 | 4 | 4 | 0000950170-23-043920 | 10775 | ||||||
| 2023-08-22 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-217481 | 001-39103 | 231191008 | 34 | 180373 | 1 | 1 |
| 2023-08-21 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-003296 | 001-39103 | 231189343 | 33 | 6173 | |||
| 2023-08-10 | S-8 | S-8 | 0001193125-23-208133 | 333-273863 | 231157231 | 33 | 57499 | |||
| 2023-08-10 | 10-Q | 10-Q | 0000950170-23-040966 | 001-39103 | 231157225 | 34 | 9468660 | 1 | 1 | |
| 2023-08-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-208095 | 001-39103 | 231157170 | 34 | 216525 | 1 | 1 |
| 2023-07-24 | 4 | 4 | 0000950170-23-033944 | 5316 | ||||||
| 2023-07-24 | 3 | 3 | 0000950170-23-033943 | 6681 | ||||||
| 2023-07-24 | 8-K | 8-K | 5.02,7.01,8.01,9.01 | 0001193125-23-191895 | 001-39103 | 231103783 | 34 | 4136219 | 1 | 1 |
| 2023-07-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-017452 | 11442 | ||||||
| 2023-07-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-002434 | 001-39103 | 231096828 | 33 | 6173 | |||
| 2023-06-21 | 4 | FORM 4 SUBMISSION | 0000899243-23-016147 | 9369 | ||||||
| 2023-06-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-001769 | 001-39103 | 231025434 | 33 | 5448 | |||
| 2023-06-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-001767 | 001-39103 | 231025422 | 33 | 5448 | |||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-014333 | 5358 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-014332 | 5378 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-014331 | 5382 | ||||||
| 2023-06-02 | 4 | FORM 4 SUBMISSION | 0000899243-23-014330 | 5370 | ||||||
| 2023-06-01 | SC 13G | SC 13G | 0001193125-23-159011 | 005-91178 | 23985354 | 34 | 49921 | |||
| 2023-06-01 | 8-K | 8-K | 5.02,5.07,9.01 | 0001193125-23-158936 | 001-39103 | 23984685 | 34 | 167927 | 1 | 1 |
| 2023-05-26 | SC 13G | e618673_sc13g-cb.htm | 0001193805-23-000796 | 005-91178 | 23967735 | 34 | 130171 | |||
| 2023-05-22 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-150530 | 001-39103 | 23945039 | 34 | 172382 | 1 | 1 |
| 2023-05-19 | 4 | FORM 4 SUBMISSION | 0000899243-23-013455 | 9368 | ||||||
| 2023-05-19 | 144 | xsl144X01/primary_doc.xml | 0001950047-23-000807 | 001-39103 | 23940556 | 33 | 4722 | |||
| 2023-05-18 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-23-148212 | 001-39103 | 23936591 | 34 | 510118 | 1 | 1 |
| 2023-05-18 | 424B5 | 424B5 | 0001193125-23-148191 | 333-270599 | 23936494 | 33 | 634918 | |||
| 2023-05-18 | 424B5 | 424B5 | 0001193125-23-147294 | 333-270599 | 23933554 | 33 | 640818 | |||
| 2023-05-16 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-146067 | 001-39103 | 23927367 | 34 | 14821507 | 1 | 1 |
| 2023-05-16 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-145622 | 001-39103 | 23925550 | 34 | 179178 | 1 | 1 |
| 2023-05-11 | 10-Q | 10-Q | 0000950170-23-020849 | 001-39103 | 23908872 | 34 | 7929927 | 1 | 1 | |
| 2023-05-11 | 8-K | 8-K | 2.02,9.01 | 0001193125-23-141371 | 001-39103 | 23908760 | 34 | 207047 | 1 | 1 |
| 2023-05-02 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-132565 | 001-39103 | 23879793 | 34 | 196065 | 1 | 1 |
| 2023-05-01 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-128724 | 001-39103 | 23869986 | 34 | 13662224 | 1 | 1 |
| 2023-04-26 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2023-04-26 16:01:00 | 9999999995-23-001056 | 333-270599 | 23851551 | 33 | 1726 | ||
| 2023-04-24 | CORRESP | filename1.htm | 0001193125-23-112827 | 6421 | ||||||
| 2023-04-21 | ARS | ARS | 0001193125-23-109213 | 001-39103 | 23834496 | 34 | 7619008 | |||
| 2023-04-21 | DEFA14A | DEFA14A | 0001193125-23-109207 | 001-39103 | 23834492 | 34 | 36345 | |||
| 2023-04-21 | DEF 14A | DEF 14A | 0001193125-23-109203 | 001-39103 | 23834488 | 34 | 573241 | |||
| 2023-03-31 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-23-086713 | 001-39103 | 23783188 | 34 | 13434602 | 1 | 1 |
| 2023-03-22 | UPLOAD | filename1.pdf | 0000000000-23-002866 | 40309 | ||||||
| 2023-03-16 | S-3 | S-3 | 0001193125-23-072030 | 333-270599 | 23737257 | 33 | 1393481 | |||
| 2023-03-16 | S-8 | S-8 | 0001193125-23-071978 | 333-270595 | 23737153 | 33 | 53610 | |||
| 2023-03-16 | 10-K | 10-K | 0000950170-23-008298 | 001-39103 | 23737124 | 34 | 11692324 | 1 | 1 | |
| 2023-03-16 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-23-071942 | 001-39103 | 23737110 | 34 | 12228458 | 1 | 1 |
| 2023-03-06 | 8-K | 8-K | 8.01,9.01 | 0001193125-23-060668 | 001-39103 | 23707513 | 34 | 12151007 | 1 | 1 |
| 2023-02-14 | SC 13G/A | CABALETTA BIO, INC. | 0000902664-23-001805 | 005-91178 | 23629074 | 34 | 66353 | |||
| 2023-02-14 | SC 13G | SC 13G | 0001104659-23-021472 | 005-91178 | 23628443 | 34 | 120345 | |||
| 2023-02-14 | SC 13G/A | sc13ga.htm | 0000929638-23-000562 | 005-91178 | 23627743 | 34 | 123688 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001104659-23-020779 | 005-91178 | 23622736 | 34 | 137802 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001019056-23-000134 | 005-91178 | 23622362 | 34 | 155645 | |||
| 2023-02-14 | SC 13G/A | SC 13G/A | 0001193125-23-036893 | 005-91178 | 23621806 | 34 | 47195 | |||
| 2023-02-10 | SC 13G | CABALETTA BIO, INC. | 0001193125-23-032530 | 005-91178 | 23611730 | 34 | 52392 | |||
| 2023-02-09 | SC 13G/A | CABALETTA BIO, INC. | 0000902664-23-001367 | 005-91178 | 23605072 | 34 | 102381 | |||
| 2023-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-002914 | 5539 | ||||||
| 2023-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-002913 | 5506 | ||||||
| 2023-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-002912 | 5522 | ||||||
| 2023-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-002910 | 5562 | ||||||
| 2023-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-002908 | 5533 | ||||||
| 2023-01-27 | 4 | FORM 4 SUBMISSION | 0000899243-23-002907 | 5527 | ||||||
| 2023-01-13 | SC 13G | formsc13g.htm | 0001493152-23-001414 | 005-91178 | 23528760 | 34 | 97696 | |||
| 2023-01-09 | 8-K | 8-K | 7.01,9.01 | 0001193125-23-004113 | 001-39103 | 23516503 | 34 | 12034800 | 1 | 1 |
| 2022-12-23 | SC 13G | SC 13G | 0001104659-22-129901 | 005-91178 | 221485543 | 34 | 231313 | |||
| 2022-12-12 | 8-K | 8-K | 1.01,8.01,9.01 | 0001193125-22-302822 | 001-39103 | 221457689 | 34 | 646844 | 1 | 1 |
| 2022-12-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-301060 | 001-39103 | 221452892 | 34 | 13157161 | 1 | 1 |
| 2022-12-08 | 424B5 | 424B5 | 0001193125-22-300489 | 333-250006 | 221451387 | 33 | 586324 | |||
| 2022-12-08 | FWP | FWP | 0001193125-22-300485 | 333-250006 | 221451382 | 34 | 64886 | |||
| 2022-11-10 | 10-Q | 10-Q | 0000950170-22-024168 | 001-39103 | 221374982 | 34 | 9813906 | 1 | 1 | |
| 2022-11-10 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-22-281920 | 001-39103 | 221374897 | 34 | 13230386 | 1 | 1 |
| 2022-11-07 | SC 13G | SC 13G | 0001193125-22-279136 | 005-91178 | 221365919 | 34 | 47054 | |||
| 2022-10-31 | SC 13G | CABALETTA BIO, INC | 0000902664-22-004692 | 005-91178 | 221346552 | 34 | 67641 | |||
| 2022-10-31 | SC 13G | sc13g.htm | 0000929638-22-001618 | 005-91178 | 221345949 | 34 | 126443 | |||
| 2022-10-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-033850 | 5619 | ||||||
| 2022-10-18 | 4 | FORM 4 SUBMISSION | 0000899243-22-033783 | 4518 | ||||||
| 2022-10-18 | 4 | FORM 4 SUBMISSION | 0000899243-22-033782 | 5098 | ||||||
| 2022-10-18 | 4 | FORM 4 SUBMISSION | 0000899243-22-033781 | 6914 | ||||||
| 2022-10-18 | 4 | FORM 4 SUBMISSION | 0000899243-22-033780 | 5134 | ||||||
| 2022-10-18 | 4 | FORM 4 SUBMISSION | 0000899243-22-033779 | 6145 | ||||||
| 2022-10-11 | 8-K | 8-K | 1.01,7.01,8.01,9.01 | 0001193125-22-260195 | 001-39103 | 221302309 | 34 | 13196022 | 1 | 1 |
| 2022-09-12 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-22-242340 | 001-39103 | 221237314 | 34 | 16397990 | 1 | 1 |
| 2022-08-29 | 8-K | 8-K | 8.01,9.01 | 0001193125-22-232575 | 001-39103 | 221210387 | 34 | 178531 | 1 | 1 |
| 2022-08-22 | SC 13G | SC 13G | 0001019056-22-000570 | 005-91178 | 221182308 | 34 | 154131 | |||
| 2022-08-11 | 10-Q | 10-Q | 0000950170-22-016650 | 001-39103 | 221153727 | 34 | 8286367 | 1 | 1 | |
| 2022-08-11 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-22-217960 | 001-39103 | 221153661 | 34 | 14635399 | 1 | 1 |
| 2022-08-03 | SC 13D/A | SC 13D/A | 0001104659-22-085691 | 005-91178 | 221133473 | 34 | 163686 | |||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-020999 | 9026 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-020998 | 9014 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-020997 | 9057 | ||||||
| 2022-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-22-020995 | 9048 | ||||||
| 2022-06-02 | 8-K | 8-K | 5.07 | 0001193125-22-165785 | 001-39103 | 22989284 | 34 | 156508 | 1 | 1 |
| 2022-05-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-22-153543 | 001-39103 | 22937023 | 34 | 14687237 | 1 | 1 |
| 2022-05-12 | 10-Q | 10-Q | 0001564590-22-019677 | 001-39103 | 22915754 | 34 | 6902052 | 1 | 1 | |
| 2022-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-22-148046 | 001-39103 | 22915665 | 34 | 206519 | 1 | 1 |
| 2022-05-02 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-136873 | 001-39103 | 22882593 | 34 | 194518 | 1 | 1 |
| 2022-04-21 | DEFA14A | DEFA14A | 0001193125-22-112143 | 001-39103 | 22839711 | 34 | 354738 | |||
| 2022-04-21 | DEF 14A | DEF 14A | 0001193125-22-112140 | 001-39103 | 22839705 | 34 | 725675 | |||
| 2022-03-17 | S-8 | S-8 | 0001193125-22-078283 | 333-263637 | 22748422 | 33 | 50550 | |||
| 2022-03-17 | 10-K | 10-K | 0001564590-22-010726 | 001-39103 | 22746853 | 34 | 16778215 | 1 | 1 | |
| 2022-03-17 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-22-077793 | 001-39103 | 22746712 | 34 | 14151256 | 1 | 1 |
| 2022-03-14 | 8-K/A | 8-K/A | 7.01,9.01 | 0001193125-22-074084 | 001-39103 | 22735116 | 34 | 13930051 | 1 | 1 |
| 2022-03-03 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-063683 | 001-39103 | 22706806 | 34 | 13939286 | 1 | 1 |
| 2022-03-01 | 8-K | 8-K | 8.01 | 0001193125-22-059886 | 001-39103 | 22694049 | 34 | 154243 | 1 | 1 |
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001104659-22-023131 | 005-91178 | 22634473 | 34 | 68366 | |||
| 2022-02-14 | SC 13G/A | SC 13G/A | 0001193125-22-041953 | 005-91178 | 22633400 | 34 | 85400 | |||
| 2022-02-14 | SC 13G/A | sc13g.htm | 0000929638-22-000486 | 005-91178 | 22630259 | 34 | 126292 | |||
| 2022-02-14 | SC 13G/A | CABALETTA BIO, INC. | 0001104659-22-021311 | 005-91178 | 22624827 | 34 | 139944 | |||
| 2022-02-10 | SC 13G/A | CABALETTA BIO, INC. | 0000902664-22-001345 | 005-91178 | 22611410 | 34 | 105222 | |||
| 2022-02-02 | 4 | FORM 4 SUBMISSION | 0000899243-22-004158 | 8240 | ||||||
| 2022-01-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-002517 | 9184 | ||||||
| 2022-01-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-002516 | 5502 | ||||||
| 2022-01-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-002514 | 5521 | ||||||
| 2022-01-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-002510 | 9213 | ||||||
| 2022-01-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-002509 | 9206 | ||||||
| 2022-01-19 | 4 | FORM 4 SUBMISSION | 0000899243-22-002508 | 9243 | ||||||
| 2022-01-13 | 3 | FORM 3 SUBMISSION | 0000899243-22-001911 | 10546 | ||||||
| 2022-01-10 | 8-K | 8-K | 7.01,9.01 | 0001193125-22-005100 | 001-39103 | 22519730 | 34 | 13219807 | 1 | 1 |
| 2021-12-14 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-356168 | 001-39103 | 211489670 | 34 | 19648842 | 1 | 1 |
| 2021-11-03 | 4 | FORM 4 SUBMISSION | 0001209191-21-062716 | 16724 | ||||||
| 2021-11-03 | SC 13D/A | SC 13D/A | 0001104659-21-133670 | 005-91178 | 211375947 | 34 | 147618 | |||
| 2021-11-01 | SC 13G | CABALETTA BIO, INC. | 0001104659-21-132336 | 005-91178 | 211367120 | 34 | 144423 | |||
| 2021-11-01 | 10-Q | 10-Q | 0001564590-21-053043 | 001-39103 | 211365315 | 34 | 8596047 | 1 | 1 | |
| 2021-11-01 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-21-314433 | 001-39103 | 211365288 | 34 | 19419476 | 1 | 1 |
| 2021-09-09 | 4 | FORM 4 SUBMISSION | 0001209191-21-055343 | 15766 | ||||||
| 2021-09-09 | SC 13D/A | SC 13D/A | 0001104659-21-114209 | 005-91178 | 211244755 | 34 | 197122 | |||
| 2021-09-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-035110 | 5403 | ||||||
| 2021-09-03 | 3 | FORM 3 SUBMISSION | 0000899243-21-035102 | 6595 | ||||||
| 2021-08-18 | 8-K | 8-K | 7.01,8.01,9.01 | 0001193125-21-249668 | 001-39103 | 211184996 | 34 | 19065381 | 1 | 1 |
| 2021-08-05 | 10-Q | 10-Q | 0001564590-21-041196 | 001-39103 | 211146386 | 34 | 8322857 | 1 | 1 | |
| 2021-08-05 | 8-K | 8-K | 2.02,7.01,9.01 | 0001193125-21-237002 | 001-39103 | 211146356 | 34 | 19416494 | ||
| 2021-06-28 | 4 | FORM 4 SUBMISSION | 0000899243-21-026198 | 5419 | ||||||
| 2021-06-28 | 4/A | FORM 4/A SUBMISSION | 0000899243-21-026199 | 5748 | ||||||
| 2021-06-28 | 3 | FORM 3 SUBMISSION | 0000899243-21-026172 | 6521 | ||||||
| 2021-06-28 | 8-K | 8-K | 5.02,9.01 | 0001193125-21-201119 | 001-39103 | 211050026 | 34 | 37625 | ||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-021795 | 5321 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-021792 | 5350 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-021793 | 5341 | ||||||
| 2021-06-03 | 4 | FORM 4 SUBMISSION | 0000899243-21-021791 | 5341 | ||||||
| 2021-06-03 | 8-K | 8-K | 5.07,7.01,9.01 | 0001193125-21-180577 | 001-39103 | 21991171 | 34 | 19716710 | ||
| 2021-05-03 | 10-Q | 10-Q | 0001564590-21-022689 | 001-39103 | 21881318 | 34 | 6162687 | 1 | ||
| 2021-05-03 | 8-K | 8-K | 2.02,7.01,8.01,9.01 | 0001193125-21-146616 | 001-39103 | 21881295 | 34 | 19890596 | ||
| 2021-04-21 | DEFA14A | DEFA14A | 0001193125-21-124712 | 001-39103 | 21841689 | 34 | 62910 | |||
| 2021-04-21 | DEF 14A | DEF 14A | 0001193125-21-124695 | 001-39103 | 21841652 | 34 | 414372 | |||
| 2021-04-06 | 8-K | 8-K | 7.01,9.01 | 0001193125-21-106915 | 001-39103 | 21808068 | 34 | 14365853 | ||
| 2021-03-16 | S-8 | S-8 | 0001193125-21-082805 | 333-254342 | 21745816 | 33 | 51473 | |||
| 2021-03-16 | 10-K | 10-K | 0001564590-21-013329 | 001-39103 | 21743703 | 34 | 10921720 | 1 | ||
| 2021-03-16 | 8-K | 8-K | 2.02,9.01 | 0001193125-21-082134 | 001-39103 | 21743642 | 34 | 71810 | ||
| 2021-03-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-009238 | 5403 | ||||||
| 2021-03-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-009237 | 5381 | ||||||
| 2021-03-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-009236 | 5387 | ||||||
| 2021-03-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-009235 | 5404 | ||||||
| 2021-03-02 | 4 | FORM 4 SUBMISSION | 0000899243-21-009234 | 5416 | ||||||
| 2021-02-16 | SC 13G/A | SC 13G/A | 0001193125-21-045272 | 005-91178 | 21641170 | 34 | 87480 | |||
| 2021-02-16 | SC 13G | SCHEDULE 13G | 0001104659-21-023925 | 005-91178 | 21638173 | 34 | 74806 | |||
| 2021-02-16 | SC 13G/A | sc13g.htm | 0000929638-21-000374 | 005-91178 | 21636893 | 34 | 125859 | |||
| 2021-02-12 | SC 13G/A | e620278_sc13ga-cabaletta.htm | 0001193805-21-000205 | 005-91178 | 21624817 | 34 | 142147 | |||
| 2021-02-11 | SC 13G/A | CABALETTA BIO, INC. | 0000902664-21-001140 | 005-91178 | 21616796 | 34 | 105953 | |||
| 2021-01-12 | 4 | FORM 4 SUBMISSION | 0001209191-21-003268 | 20715 | ||||||
| 2021-01-12 | SC 13D/A | SC 13D/A | 0001104659-21-003503 | 005-91178 | 21524107 | 34 | 221006 | |||
| 2020-12-14 | 4 | FORM 4 SUBMISSION | 0001209191-20-063298 | 16985 | ||||||
| 2020-12-14 | SC 13D/A | SC 13D/A | 0001104659-20-135319 | 005-91178 | 201387049 | 34 | 209968 | |||
| 2020-12-11 | 424B5 | 424B5 | 0001193125-20-315931 | 333-250006 | 201383871 | 33 | 280794 | |||
| 2020-12-09 | 4 | FORM 4 SUBMISSION | 0000899243-20-033173 | 7315 | ||||||
| 2020-12-08 | 8-K | 8-K | 8.01 | 0001193125-20-312789 | 001-39103 | 201375767 | 34 | 21740 | ||
| 2020-11-18 | EFFECT | xslEFFECTX01/primary_doc.xml | S-3,,2020-11-18 16:01:00 | 9999999995-20-003226 | 333-250006 | 201326992 | 33 | 1727 | ||
| 2020-11-16 | CORRESP | filename1.htm | 0001193125-20-294729 | 7039 | ||||||
| 2020-11-16 | UPLOAD | filename1.pdf | 0000000000-20-010939 | 40122 | ||||||
| 2020-11-10 | S-3 | S-3 | 0001193125-20-290208 | 333-250006 | 201301592 | 33 | 1410639 | |||
| 2020-11-10 | 10-Q | 10-Q | 0001564590-20-052757 | 001-39103 | 201299732 | 34 | 7732654 | 1 | ||
| 2020-11-10 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-289674 | 001-39103 | 201299691 | 34 | 68030 | ||
| 2020-09-16 | 4 | FORM 4 SUBMISSION | 0000899243-20-025326 | 5400 | ||||||
| 2020-08-06 | 10-Q | 10-Q | 0001564590-20-037278 | 001-39103 | 201079939 | 34 | 7497703 | 1 | ||
| 2020-08-06 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-211336 | 001-39103 | 201079844 | 34 | 62853 | ||
| 2020-07-21 | SC 13G | CABALETTA BIO, INC. | 0000902664-20-002724 | 005-91178 | 201038109 | 34 | 113747 | |||
| 2020-06-03 | 8-K | 8-K | 5.07,7.01,9.01 | 0001193125-20-159049 | 001-39103 | 20938875 | 34 | 13258630 | ||
| 2020-05-28 | 8-K | 8-K | 1.01,9.01 | 0001193125-20-153792 | 001-39103 | 20917236 | 34 | 118976 | ||
| 2020-05-12 | 10-Q | 10-Q | 0001564590-20-024508 | 001-39103 | 20867442 | 34 | 5762386 | 1 | ||
| 2020-05-12 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-139782 | 001-39103 | 20867031 | 34 | 62788 | ||
| 2020-05-06 | 8-K | 8-K | 8.01 | 0001193125-20-134391 | 001-39103 | 20851223 | 34 | 20365 | ||
| 2020-04-23 | DEF 14A | DEF 14A | 0001193125-20-115863 | 001-39103 | 20809160 | 34 | 535140 | |||
| 2020-03-30 | S-8 | S-8 | 0001193125-20-091086 | 333-237484 | 20758154 | 33 | 48961 | |||
| 2020-03-30 | 10-K | 10-K | 0001564590-20-013929 | 001-39103 | 20754707 | 34 | 8943004 | 1 | ||
| 2020-03-30 | 8-K | 8-K | 2.02,9.01 | 0001193125-20-090013 | 001-39103 | 20754030 | 34 | 78354 | ||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-006867 | 5387 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-006865 | 5401 | ||||||
| 2020-03-03 | 4 | FORM 4 SUBMISSION | 0000899243-20-006864 | 5378 | ||||||
| 2020-02-20 | 8-K | 8-K | 7.01,9.01 | 0001193125-20-042689 | 001-39103 | 20632567 | 34 | 22166742 | ||
| 2020-02-14 | SC 13G/A | SC 13G/A | 0001193125-20-038349 | 005-91178 | 20620606 | 34 | 112201 | |||
| 2020-02-14 | SC 13G/A | sc13g.htm | 0000929638-20-000331 | 005-91178 | 20619457 | 34 | 125859 | |||
| 2020-02-13 | 5 | FORM 5 SUBMISSION | 0000899243-20-004511 | 7775 | ||||||
| 2020-02-13 | 4 | FORM 4 SUBMISSION | 0000899243-20-004509 | 5422 |
One latest value per concept from companyfacts (218 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 215.72M | 2026-10-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 137.00M | 2025-06-30 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 838,741 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-183557 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 973,267 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-183557 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 1.65M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-183557 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 1.94M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-183557 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 23.68 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-28 | 0001193125-26-183557 | ||
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 9.04M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 368,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | AccretionExpense | Accretion Expense | USD | 312,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 7.15M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 948.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 5.26M | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 3.02M | 2025-05-19 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 18.53M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | Assets | Assets | USD | 336.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 309.85M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 25,000 | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 3,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001193125-25-273280 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 133.57M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | AvailableForSaleEquitySecuritiesGrossUnrealizedGain | Available-for-sale Equity Securities, Gross Unrealized Gain | USD | 11,000 | 2020-04-01 | 2020-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037278 |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 133.60M | 2025-12-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 265,000 | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-13 | 0001759138-26-000039 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 299.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | CashCashEquivalentsAndShortTermInvestments | Cash, Cash Equivalents, and Short-term Investments | USD | 299.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations | USD | 299.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect | USD | -22.63M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-126733 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 216.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 | Class of Warrant or Right, Exercise Price of Warrants or Rights | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 3.09M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 53.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | CommonStockDividendsPerShareDeclared | Common Stock, Dividends, Per Share, Declared | USD/shares | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001564590-20-013929 |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2019-10-16 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 600.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 100.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 100.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -147.61M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ConversionOfStockAmountConverted1 | Conversion of Stock, Amount Converted | USD | 97.95M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 |
| us-gaap | DebtConversionConvertedInstrumentAmount1 | Debt Conversion, Converted Instrument, Amount | USD | 18.78M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001564590-20-013929 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedGainLoss | Debt Securities, Available-for-sale, Unrealized Gain (Loss) | USD | -25,000 | 2026-01-01 | 2026-03-31 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 163.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 5.19M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsDomestic | Deferred Tax Assets, Operating Loss Carryforwards, Domestic | USD | 257.61M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsForeign | Deferred Tax Assets, Operating Loss Carryforwards, Foreign | USD | 319.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsNotSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Not Subject to Expiration | USD | 319.64M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal | Deferred Tax Assets, Operating Loss Carryforwards, State and Local | USD | 83.01M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwardsSubjectToExpiration | Deferred Tax Assets, Operating Loss Carryforwards, Subject to Expiration | USD | 250,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 25.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 13.30M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 2.81M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 157.85M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | DefinedContributionPlanCostRecognized | Defined Contribution Plan, Cost | USD | 1.06M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercent | Defined Contribution Plan, Employer Matching Contribution, Percent of Employees' Gross Pay | pure | 0.03 | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-03-17 | 0001564590-22-010726 |
| us-gaap | DefinedContributionPlanEmployerMatchingContributionPercentOfMatch | Defined Contribution Plan, Employer Matching Contribution, Percent of Match | pure | 0.04 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 91,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-12-05 | 0001564590-19-045375 | |
| us-gaap | Depreciation | Depreciation | USD | 1.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | Dividends | Dividends | USD | 5.33M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 |
| us-gaap | DueToRelatedPartiesCurrentAndNoncurrent | Due to Related Parties | USD | 13,000 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -0.98 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -0.45 | 2022-01-01 | 2022-03-31 | 2022 | Q1 | 10-Q | 2022-05-12 | 0001564590-22-019677 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -0.98 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.329 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047201 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectAmount | USD | 94,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | EffectiveIncomeTaxRateReconciliationCrossBorderTaxEffectPercent | pure | -0.001 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpense | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent | pure | 0.033 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001564590-20-013929 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.006 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingenciesDomestic | Effective Income Tax Rate Reconciliation, Tax Contingency, Domestic, Percent | pure | -0.259 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.056 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.053 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047201 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -38,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 7.95M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 31.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | FairValueAssetsLevel1ToLevel2TransfersAmount | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-01 | 0001564590-21-053043 | |
| us-gaap | FairValueAssetsLevel2ToLevel1TransfersAmount | Fair Value, Assets, Level 2 to Level 1 Transfers, Amount | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-01 | 0001564590-21-053043 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersNet | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers, Net | USD | 0 | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-11-01 | 0001564590-21-053043 |
| us-gaap | FinanceLeaseInterestExpense | Finance Lease, Interest Expense | USD | 2.00M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | FinanceLeaseLiabilityCurrent | Finance Lease, Liability, Current | USD | 13.68M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | FinanceLeaseLiabilityNoncurrent | Finance Lease, Liability, Noncurrent | USD | 4.74M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDue | Finance Lease, Liability, Payment, Due | USD | 18.42M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueInNextRollingTwelveMonths | Finance Lease, Liability, Payments, Due in Next Rolling Twelve Months | USD | 21.91M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueInRollingYearTwo | Finance Lease, Liability, Payments, Due in Rolling Year Two | USD | 3.28M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | FinanceLeaseLiabilityPaymentsDueNextTwelveMonths | Finance Lease, Liability, to be Paid, Year One | USD | 15.50M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | FinanceLeaseLiabilityPaymentsRemainderOfFiscalYear | Finance Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 4.37M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | FinanceLeaseLiabilityUndiscountedExcessAmount | Finance Lease, Liability, Undiscounted Excess Amount | USD | 1.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | FinanceLeasePrincipalPayments | Finance Lease, Principal Payments | USD | 11.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | FinanceLeaseRightOfUseAsset | Finance Lease, Right-of-Use Asset, after Accumulated Amortization | USD | 12.36M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | FinanceLeaseRightOfUseAssetAmortization | Finance Lease, Right-of-Use Asset, Amortization | USD | 3.10M | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-03-31 | 0000950170-25-047201 |
| us-gaap | FinanceLeaseWeightedAverageDiscountRatePercent | Finance Lease, Weighted Average Discount Rate, Percent | pure | 0.1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | ForeignCurrencyTransactionLossBeforeTax | Foreign Currency Transaction Loss, before Tax | USD | 81,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | GainLossOnTerminationOfLease | Gain (Loss) on Termination of Lease | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034422 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | 0 | 2022-01-01 | 2022-06-30 | 2022 | Q2 | 10-Q | 2022-08-11 | 0000950170-22-016650 |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 22.10M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 24,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -35.30M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 983,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | IncomeTaxReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount | USD | 203,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | IncomeTaxReconciliationTaxContingenciesDomestic | Effective Income Tax Rate Reconciliation, Tax Contingency, Domestic, Amount | USD | 43.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | IncomeTaxReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Amount | USD | 9.49M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 452,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | IncreaseDecreaseInDeferredCharges | Increase (Decrease) in Deferred Charges | USD | 817,000 | 2019-01-01 | 2019-06-30 | 2020 | Q2 | 10-Q | 2020-08-06 | 0001564590-20-037278 |
| us-gaap | IncreaseDecreaseInInterestPayableNet | Increase (Decrease) in Interest Payable, Net | USD | -381,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | IncreaseDecreaseInOperatingLeaseLiability | IncreaseDecreaseInOperatingLeaseLiability | USD | -3.23M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 3.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 5.19M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | InterestExpense | Interest Expense | USD | 1.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 2.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 4.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | LeaseCost | Lease, Cost | USD | 4.42M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 4.75M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearFour | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Four | USD | 158,000 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-12-05 | 0001564590-19-045375 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearThree | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Three | USD | 1.15M | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-11-10 | 0000950170-22-024168 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueInRollingYearTwo | Lessee, Operating Lease, Liability, Payments, Due in Rolling Year Two | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextRollingTwelveMonths | Lessee, Operating Lease, Liability, Payments, Due Next Rolling Twelve Months | USD | 3.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 292,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | Liabilities | Liabilities | USD | 52.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 336.49M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 47.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | LongTermInvestments | Long-term Investments | USD | 1.33M | 2020-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-052757 | |
| us-gaap | ManufacturingCosts | Manufacturing Costs | USD | 29.64M | 2025-01-01 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-11-10 | 0001193125-25-273280 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 292.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | 50.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | -126.82M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -147.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -33.34M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 |
| us-gaap | NoninterestExpenseOfferingCost | Noninterest Expense Offering Cost | USD | 0 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-15 | 0000950170-24-060045 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | Segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | NumberOfReportingUnits | Number of Reporting Units | Segment | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 151.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -151.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | OperatingLeaseCost | Operating Lease, Cost | USD | 4.21M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 1.13M | 2022-01-01 | 2022-09-30 | 2023 | Q3 | 10-Q | 2023-11-09 | 0000950170-23-061528 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 953,000 | 2023-10-01 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-126733 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 4.25M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 502,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 3.19M | 2024-01-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-11-14 | 0000950170-24-126733 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 4.71M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 5.02M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034422 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 2.28M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0000950170-23-008298 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree | Operating Leases, Future Minimum Payments, Due in Rolling Year Three | USD | 1.15M | 2022-12-31 | 2022 | FY | 10-K | 2023-03-16 | 0000950170-23-008298 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwo | Operating Leases, Future Minimum Payments, Due in Rolling Year Two | USD | 1.64M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034422 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths | Operating Leases, Future Minimum Payments, Next Rolling Twelve Months | USD | 3.75M | 2023-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034422 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.1 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 8.57M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -25,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 70,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | OtherOperatingIncomeExpenseNet | Other Operating Income (Expense), Net | USD | 278,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | OtherResearchAndDevelopmentExpense | Other Research and Development Expense | USD | 2.73M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | PaymentsForCommissions | Payments for Commissions | USD | 1.11M | 2025-04-01 | 2025-06-30 | 2025 | Q2 | 10-Q | 2025-08-07 | 0000950170-25-104573 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 147,000 | 2024-01-01 | 2024-03-31 | 2025 | Q1 | 10-Q | 2025-05-15 | 0000950170-25-071971 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 142,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 10.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 10.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 12.54M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001564590-20-013929 |
| us-gaap | ProceedsFromIssuanceInitialPublicOffering | Proceeds from Issuance Initial Public Offering | USD | 71.03M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-12-05 | 0001564590-19-045375 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 128.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ProceedsFromIssuanceOfConvertiblePreferredStock | Proceeds from Issuance of Convertible Preferred Stock | USD | 50.00M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 160,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 50.96M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 167,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -147.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 9.07M | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 1.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | ReclassificationsOfTemporaryToPermanentEquity | Reclassifications of Temporary to Permanent Equity | USD | -5.33M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 128.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -664.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability | Right-of-Use Asset Obtained in Exchange for Finance Lease Liability | USD | 4.21M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 7.27M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 16.02M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 1.16 | 2026-01-01 | 2026-03-31 | 2026 | Q1 | 10-Q | 2026-05-14 | 0001759138-26-000026 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum | pure | 1.18 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum | pure | 1.12 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum | pure | 0.051 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum | pure | 0.037 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period | shares | 108,949 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0000950170-24-093325 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 2.74 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price | USD/shares | 14.96 | 2024-01-01 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-08 | 0000950170-24-093325 |
| us-gaap | ShortTermInvestments | Short-term Investments | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | ShortTermLeaseCost | Short-term Lease, Cost | USD | 34,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants | Stock and Warrants Issued During Period, Value, Preferred Stock and Warrants | USD | 32.56M | 2022-01-01 | 2022-12-31 | 2023 | FY | 10-K | 2024-03-21 | 0000950170-24-034422 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 283.92M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | StockholdersEquityNoteStockSplitConversionRatio1 | Stockholders' Equity Note, Stock Split, Conversion Ratio | pure | 0.67 | 2019-10-15 | 2019-10-16 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfUnits | Stock Issued During Period, Value, Conversion of Units | USD | 97.95M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 160,000 | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 1.16M | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001564590-20-013929 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 140.20M | 2026-04-01 | 2026-06-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 101,000 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | TemporaryEquityCarryingAmountAttributableToParent | Temporary Equity, Carrying Amount, Attributable to Parent | USD | 43.92M | 2018-12-31 | 2019 | FY | 10-K | 2020-03-30 | 0001564590-20-013929 | |
| us-gaap | TemporaryEquityLiquidationPreference | Temporary Equity, Liquidation Preference | USD | 94.47M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-12-05 | 0001564590-19-045375 | |
| us-gaap | TemporaryEquitySharesAuthorized | Temporary Equity, Shares Authorized | shares | 20.76M | 2019-01-31 | 2020 | FY | 10-K | 2021-03-16 | 0001564590-21-013329 | |
| us-gaap | TemporaryEquitySharesIssued | Temporary Equity, Shares Issued | shares | 0 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-12-05 | 0001564590-19-045375 | |
| us-gaap | TemporaryEquitySharesOutstanding | Temporary Equity, Shares Outstanding | shares | 19.36M | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-12-05 | 0001564590-19-045375 | |
| us-gaap | TemporaryEquityStockIssuedDuringPeriodValueNewIssues | Temporary Equity, Stock Issued During Period, Value, New Issues | USD | 50.00M | 2019-01-01 | 2019-09-30 | 2019 | Q3 | 10-Q | 2019-12-05 | 0001564590-19-045375 |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 | |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued | Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 47.13M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | VariableLeaseCost | Variable Lease, Cost | USD | 171,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-03-23 | 0001759138-26-000011 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 150.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 1.81M | 2019-01-01 | 2019-09-30 | 2020 | Q3 | 10-Q | 2020-11-10 | 0001564590-20-052757 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 150.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-05 | 0001759138-26-000047 |